Wisconsin Wealth Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$747K Sell
2,967
-35
-1% -$7.53K 0.64% 49
2026
Q1
$653K Sell
3,002
-1,085
-27% -$241K 0.64% 51
2025
Q4
$934K Sell
4,087
-1,860
-31% -$424K 0.92% 39
2025
Q3
$1.38M Sell
5,947
-47
-0.8% -$9.57K 1.31% 25
2025
Q2
$1.11M Buy
5,994
+245
+4% +$45.5K 1.28% 25
2025
Q1
$1.2M Buy
5,749
+1
+0% +$194 1.73% 19
2024
Q4
$1.02M Buy
+5,748
New +$1.06M 1.51% 23

Other funds holding ABBV

Wisconsin Wealth Advisors's ABBV Position: Q2 2026 in Review

Wisconsin Wealth Advisors reduced its AbbVie (ABBV) stake by 1.2% in Q2 2026, selling an estimated $7.53K and leaving 2,967 shares worth $747K. The position accounts for 0.64% of the portfolio, ranked #49.

Wisconsin Wealth Advisors first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.38M in Q3 2025. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Wisconsin Wealth Advisors held 2,967 shares of AbbVie worth $747K as of Q2 2026.
  • Wisconsin Wealth Advisors sold 35 AbbVie shares in Q2 2026, an estimated $7.53K.
  • AbbVie made up 0.64% of Wisconsin Wealth Advisors's portfolio in Q2 2026, its #49 holding.
  • Wisconsin Wealth Advisors first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • Wisconsin Wealth Advisors's AbbVie position peaked at $1.38M in Q3 2025.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Wisconsin Wealth Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.